Outcomes of autologous transplantation for multiple myeloma according to different induction regimens.

ABSTRACT:

Background

Induction therapy followed by high-dose chemotherapy and autologous transplantation is the standard treatment for suitable patients with multiple myeloma.

Objective

The aim of this study was to assess whether induction therapy with thalidomidecontaining regimens was associated with improved results compared to vincristine, doxorubicin, and dexamethasone, and whether cyclophosphamide, thalidomide, and dexamethasone were associated with better results than thalidomide and dexamethasone.

Methods

The records of 152 patients who underwent autologous transplantation at this institution from August of 2004 to January of 2012 were reviewed, selecting those with at least partial response to a maximum of eight cycles of induction therapy and sufficient follow-up info

SUBMITTER: Crusoe Ede Q 

PROVIDER: S-EPMC3948661 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature